JOSÉ ANTONIO
LORENTE ACOSTA
CATEDRÁTICO DE UNIVERSIDAD
Hospital Universitario Virgen de las Nieves
Granada, EspañaPublicaciones en colaboración con investigadores/as de Hospital Universitario Virgen de las Nieves (44)
2024
2023
-
Baseline extracellular vesicle miRNA-30c and autophagic CTCs predict chemoradiotherapy resistance and outcomes in patients with lung cancer
Biomarker Research
-
Follow-Up Biomarkers in the Evolution of Prostate Cancer, Levels of S100A4 as a Detector in Plasma
International Journal of Molecular Sciences, Vol. 24, Núm. 1
2022
-
A Novel, Quick, and Reliable Smartphone-Based Method for Serum PSA Quantification: Original Design of a Portable Microfluidic Immunosensor-Based System
Cancers, Vol. 14, Núm. 18
-
Exchange of cellular components between platelets and tumor cells: impact on tumor cells behavior
Theranostics, Vol. 12, Núm. 5, pp. 2150-2161
-
Hepatocellular carcinoma risk-stratification based on ASGR1 in circulating epithelial cells for cancer interception
Frontiers in Molecular Biosciences, Vol. 9
-
Identification of hereditary breast and ovarian cancer germline variants in Granada (Spain): NGS perspective
Molecular Genetics and Genomics, Vol. 297, Núm. 3, pp. 859-871
-
Type 2 Diabetes-Related Variants Influence the Risk of Developing Prostate Cancer: A Population-Based Case-Control Study and Meta-Analysis
Cancers, Vol. 14, Núm. 10
2021
-
Combined genome, transcriptome and metabolome analysis in the diagnosis of childhood cerebellar ataxia
International Journal of Molecular Sciences, Vol. 22, Núm. 6, pp. 1-19
-
Cross‐resistance to abiraterone and enzalutamide in castration resistance prostate cancer cellular models is mediated by ar transcriptional reactivation
Cancers, Vol. 13, Núm. 6, pp. 1-21
-
Deep phenotypic characterisation of CTCs by combination of microfluidic isolation (Isoflux) and imaging flow cytometry (imagestream)
Cancers, Vol. 13, Núm. 24
-
Identification of mirnas as viable aggressiveness biomarkers for prostate cancer
Biomedicines, Vol. 9, Núm. 6
2020
-
Extracellular vesicle-miRNAs as liquid biopsy biomarkers for disease identification and prognosis in metastatic colorectal cancer patients
Scientific Reports, Vol. 10, Núm. 1
-
From precision medicine to imprecision medicine through limited diagnostic ability to detect low allelic frequency mutations
Translational Lung Cancer Research, Vol. 9, Núm. 2, pp. 180-183
-
Liquid biopsy and prostate cancer. Current evidence applied to clinical practice
Actas Urologicas Espanolas, Vol. 44, Núm. 3, pp. 139-147
-
Precision prevention and cancer interception: The new challenges of liquid biopsy
Cancer Discovery, Vol. 10, Núm. 11, pp. 1635-1644
-
Strategies for isolation and phenotypic, genetic, and functional characterization of circulating tumor cells
Cancers
-
The polemic diagnostic role of TP53 mutations in liquid biopsies from breast, colon and lung cancers
Cancers, Vol. 12, Núm. 11, pp. 1-17
2019
-
Cooperative and Escaping Mechanisms between Circulating Tumor Cells and Blood Constituents
Cells, Vol. 8, Núm. 11
-
GSTM1 gene expression and copy number variation in prostate cancer patients—Effect of chemical exposures and physical activity
Urologic Oncology: Seminars and Original Investigations, Vol. 37, Núm. 4, pp. 290.e9-290.e15